We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Cookies & Data Use Policy
At Power, we believe in using data responsibly to help you find the right clinical trials — without compromising your privacy. This page explains how we use cookies and personal data across www.withpower.com.
When you browse Power's website, you're opting in to our use of cookies. Cookies are used to improve your experience and help us understand how the site is used so that we can make improvements for you in the future. Specifically, we use cookies to:
We use cookies to customize your visit based on basic information like your general location (determined by your IP address). This allows us to:
We remember what you interact with during your visit — for example:
This helps us make your experience more efficient and personalized the next time you visit.
Cookies help us collect anonymous usage data so we can make Power better. We use these insights to:
These analytics are aggregated and do not include personal identifiers. We use tools like Google Analytics to process this data, but we don't use it to target ads or sell your information.
We do not:
All cookie use is designed to support your experience on Power — never to track you across the internet or monetize your information.
When you sign up for a Power account, you agree to our Privacy Policy and Terms of Service. Creating a profile allows us to better serve you by tailoring the platform to your specific needs.
Once you create a profile:
We use your data solely to fulfill our mission: helping you find clinical trials that could be a fit — not for advertising or resale.
Condition
Location
By Condition
By Location
By Subject
By Trial
Search Clinical Trials
Conditions
Locations
Treatment Type
Trial Phase
Trial Status
Paid Participation
Trial Details
Key Eligibility Criteria
225 Participants Needed
Trial Details
Key Eligibility Criteria
1535 Participants Needed
Trial Details
Key Eligibility Criteria
2996 Participants Needed
Trial Details
Key Eligibility Criteria
1736 Participants Needed
Trial Details
Key Eligibility Criteria
352 Participants Needed
Trial Details
Key Eligibility Criteria
600 Participants Needed
Trial Details
Key Eligibility Criteria
180 Participants Needed
Trial Details
Key Eligibility Criteria
135 Participants Needed
Trial Details
Key Eligibility Criteria
540 Participants Needed
Trial Details
Key Eligibility Criteria
102 Participants Needed
Trial Details
Key Eligibility Criteria
20 Participants Needed
Trial Details
Key Eligibility Criteria
406 Participants Needed
Trial Details
Key Eligibility Criteria
100 Participants Needed
Trial Details
Key Eligibility Criteria
50 Participants Needed
Trial Details
Key Eligibility Criteria
48 Participants Needed
Trial Details
Key Eligibility Criteria
3000 Participants Needed
Trial Details
Key Eligibility Criteria
128 Participants Needed
Trial Details
Key Eligibility Criteria
76 Participants Needed
Trial Details
Key Eligibility Criteria
60 Participants Needed
Trial Details
Key Eligibility Criteria
50 Participants Needed
"I'm so used to losing things, forgetting things, making up to acronyms to remember things only to remember the acromym but not what the letters stand for... I enter a new room to look for an item, only to forget what I was looking for. I've discussed the existing treatments with my neurologist and she's on board with my joining a clinical trial."
"I have a very strong family history of Alzheimer’s, with my maternal grandmother, mother, uncle, and sister having the disease. My APOE status is 2/4. My memory is going, although 6 months ago I tested decently on some cognitive tests. I'd like to help myself by getting ahead of my condition and help others in a similar situation by participating in medical research."
"I have been on standard Alzheimer's medication for a few years but know this treatment only works to delay my cognitive deterioration, not improve it. I've been doing research, which brought me here, to consider some of the latest research drugs. While I know that there's no guarantee that a clinical trial improves my condition, I'd like to give one a try and help further the research for all."
"I watched my mother die from Parkinson’s. At the time of her death, she weighed 85 pounds and could not move any muscles voluntarily except her eyelids. I would like to participate in a trial to help find a better treatment for PD than what is currently available. It is a devastating illness. It breaks my heart that other families will have to go through this."
"I watched my mother suffer through years of Alzheimer's Disease and I want to help advance the science for treating AD. I don't want anyone else to have go through what our family went through."
Trial Details
Key Eligibility Criteria
1 Participants Needed
Trial Details
Key Eligibility Criteria
355 Participants Needed
Trial Details
Key Eligibility Criteria
8000 Participants Needed
Trial Details
Key Eligibility Criteria
310 Participants Needed
Trial Details
Key Eligibility Criteria
822 Participants Needed
Trial Details
Key Eligibility Criteria
380 Participants Needed
Trial Details
Key Eligibility Criteria
36 Participants Needed
Trial Details
Key Eligibility Criteria
240 Participants Needed
Trial Details
Key Eligibility Criteria
50 Participants Needed
Trial Details
Key Eligibility Criteria
1197 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Alzheimer's Disease trials in Wisconsin 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Wisconsin for Alzheimer's Disease is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Wisconsin several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added KarXT + KarX-EC for Alzheimer's Disease, Anti-amyloid Immunotherapies for Alzheimer's Disease and KarXT + KarX-EC for Agitation in Alzheimer's Disease to the Power online platform.